What is the diagnosis and management for a 31-year-old man with 7 days of right ear, jaw and throat pain and a new vesicular rash, who had prior chickenpox?

Diagnosis: Ramsay Hunt Syndrome (Herpes Zoster Oticus)

This patient has Ramsay Hunt syndrome—reactivation of varicella-zoster virus (VZV) in the geniculate ganglion of the facial nerve, presenting with right ear pain, jaw pain, throat pain, and a vesicular rash. 1 The combination of otalgia with a painful vesicular eruption in a patient with prior chickenpox is pathognomonic for VZV reactivation affecting the cranial nerve ganglia. 1

Clinical Reasoning

The key diagnostic features here are:

• Unilateral ear, jaw, and throat pain for 7 days followed by a vesicular rash indicates VZV reactivation in the geniculate ganglion (cranial nerve VII) with possible involvement of the trigeminal nerve (V3 mandibular division). 1, 2

• Prior chickenpox history establishes that latent VZV resides in his sensory ganglia and can reactivate decades later. 1

• The vesicular rash with soreness is the hallmark of active herpes zoster—the virus travels along the nerve to produce the characteristic dermatomal eruption. 1

• Ramsay Hunt syndrome specifically causes vesicles on the external ear canal and posterior auricle, severe otalgia, and can include facial paralysis, loss of taste on the anterior two-thirds of the tongue, and decreased lacrimation. 1

The differential diagnosis of viral otalgia with vesicles is narrow: herpes simplex can cause similar lesions but typically lacks the dermatomal distribution and severe neuralgia seen here. 1

Immediate Management

First-Line Antiviral Therapy

Initiate oral valacyclovir 1000 mg three times daily immediately, continuing for 7–10 days until all lesions have completely scabbed. 3 Valacyclovir offers superior bioavailability compared to acyclovir and requires less frequent dosing (three times daily vs. five times daily), which improves adherence. 3

• Alternative: Acyclovir 800 mg orally five times daily for 7–10 days is equally effective but requires more frequent dosing. 3, 4

• Treatment must be started within 72 hours of rash onset for optimal efficacy in reducing acute pain, accelerating lesion healing, and preventing postherpetic neuralgia. 3 This patient is on day 8 of symptoms (7 days of pain + 1 day of rash), so immediate initiation is critical even though the ideal window has passed.

• Continue treatment until all lesions have completely scabbed, not just for an arbitrary 7-day period—this is the key clinical endpoint. 3

Adjunctive Corticosteroid Therapy

Add oral prednisone 60 mg daily for 7 days (or prednisolone equivalent) as adjunctive therapy to antivirals in Ramsay Hunt syndrome. 3 Corticosteroids may improve facial nerve recovery when combined with antivirals, though the evidence is mixed. 1

• Contraindications to prednisone include poorly controlled diabetes, history of steroid-induced psychosis, severe osteoporosis, or prior severe steroid toxicity. 3

Pain Management

Initiate gabapentin 300 mg orally at bedtime, titrating up to 300 mg three times daily over 3–5 days, with a target dose of 2400 mg/day in divided doses for acute neuropathic pain. 3 Gabapentin is first-line for acute zoster-related neuralgia and improves sleep quality, though somnolence occurs in approximately 80% of patients. 3

• Over-the-counter analgesics (acetaminophen or ibuprofen) should be used concurrently for acute pain relief. 3

• Topical ice or cold packs can reduce pain and swelling during the acute phase. 3

Red Flags Requiring Escalation to Intravenous Therapy

Switch to intravenous acyclovir 10 mg/kg every 8 hours if any of the following develop: 3

• Disseminated disease (≥3 dermatomes, visceral involvement, or hemorrhagic lesions)
• CNS complications (encephalitis, meningitis, altered mental status, severe headache, or focal neurological deficits)
• Complicated ocular disease (if the ophthalmic division V1 becomes involved)
• Severe immunosuppression (active chemotherapy, HIV with low CD4 count, organ transplant)
• Lack of clinical improvement after 7–10 days of oral therapy, suggesting possible acyclovir resistance 3

For this immunocompetent 31-year-old, oral therapy is appropriate unless complications develop. 3

Monitoring and Follow-Up

• Assess for facial nerve involvement: Check for facial weakness, loss of taste, or decreased lacrimation—these indicate geniculate ganglion involvement and may require more aggressive management. 1

• Baseline renal function should be obtained before starting valacyclovir, with dose adjustment if creatinine clearance <50 mL/min. 3 For CrCl 30–49 mL/min, reduce to 500 mg–1 g every 12 hours; for CrCl 10–29 mL/min, reduce to 500 mg–1 g every 24 hours. 3

• Ensure adequate hydration during antiviral therapy to reduce the risk of crystalluria and acyclovir-induced nephropathy. 3

• Monitor for lesion healing: If lesions have not begun to resolve within 7–10 days, suspect acyclovir resistance and obtain viral culture with susceptibility testing. 3

Infection Control

The patient is contagious from 1–2 days before rash onset until all lesions have dried and crusted (typically 4–7 days after rash onset). 5 He should:

• Avoid contact with pregnant women, premature infants, immunocompromised persons, and anyone without a history of chickenpox or varicella vaccination. 5
• Cover all lesions completely with clothing or dressings. 5
• Wash hands frequently and use separate towels and pillows from household members. 5

Prevention of Future Episodes

After recovery from this acute episode, strongly recommend the recombinant zoster vaccine (Shingrix) in two doses, even though he is only 31 years old. 1, 3 While the vaccine is FDA-approved for adults ≥50 years, this patient has demonstrated VZV reactivation and may benefit from vaccination to prevent future recurrences, particularly if he has any underlying immune dysfunction. 1

Common Pitfalls to Avoid

• Do not use topical antivirals—they are substantially less effective than systemic therapy and are not recommended. 3

• Do not stop antiviral therapy at exactly 7 days if lesions are still forming or have not completely scabbed; short-course therapy designed for genital herpes is inadequate for VZV infection. 3

• Do not apply topical corticosteroid cream to active vesicular lesions—this can worsen the infection by suppressing local immune response and increasing the risk of dissemination. 3

• Do not assume the patient is non-contagious once antiviral therapy starts—viral shedding continues until lesions are fully crusted. 5